Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline gene expression and dynamic endocrine therapy use in ER+ breast cancer: associations with recurrence in a real-world cohort.

Research square·2026
Same author

A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells.

Nature biotechnology·2026
Same author

DREAM repressive activity links somatic mutation, lifespan and disease.

Nature aging·2026
Same author

A foundation model of cancer genotype enables precise predictions of therapeutic response.

Cancer discovery·2026
Same author

Deep Learning of Histopathology Predicts Outcomes After Surgery for Pancreatic Cancer.

JCO clinical cancer informatics·2026
Same author

Common and rare genetic variants show network convergence for a majority of human traits.

EMBO reports·2026

Related Experiment Video

Updated: Jun 3, 2025

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.9K

The Hallmarks of Predictive Oncology.

Akshat Singhal1, Xiaoyu Zhao2, Patrick Wall3

  • 1Department of Computer Science and Engineering, University of California, San Diego, La Jolla, California.

Cancer Discovery
|January 6, 2025
PubMed
Summary

Artificial intelligence (AI) in precision oncology requires fundamental concepts for progress. These hallmarks aim to establish standards for AI and precision oncology development.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

4.8K

Related Experiment Videos

Last Updated: Jun 3, 2025

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.9K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

4.8K

Area of Science:

  • * Artificial Intelligence and Machine Learning in Oncology
  • * Computational Biology and Bioinformatics
  • * Genomics and Personalized Medicine

Background:

  • * Rapid advancements in artificial intelligence (AI) necessitate a framework for its application in healthcare.
  • * Precision oncology leverages individual patient data for tailored cancer treatment.
  • * Integrating AI into precision oncology requires clear guidelines for effective implementation.

Purpose of the Study:

  • * To define fundamental hallmarks for the progress of predictive modeling in precision oncology.
  • * To establish standards and guidelines for the symbiotic development of AI and precision oncology.
  • * To facilitate the timely adoption of AI-driven tools in cancer care.

Main Methods:

  • * Conceptual framework development based on expert consensus.
  • * Literature review of AI applications in precision oncology.
  • * Identification of key principles for AI-guided cancer treatment strategies.

Main Results:

  • * Defined essential hallmarks encompassing data quality, model interpretability, clinical validation, and ethical considerations.
  • * Outlined standards for AI development and deployment in precision oncology settings.
  • * Proposed guidelines to foster collaboration between AI researchers and oncologists.

Conclusions:

  • * The proposed hallmarks provide a foundational structure for advancing AI in precision oncology.
  • * Adherence to established standards will accelerate the integration of AI tools into clinical practice.
  • * These guidelines promote a synergistic relationship between AI innovation and personalized cancer therapy.